Sanofi India is engaged in Business of Manufacture and sale of pharmaceutical products.
Financial Results:
Sanofi India Ltd reported Revenues for Q1FY24 of ₹706.00 Crores up from ₹699.00 Crore year on year, a rise of 1.0%.
Total Expenses for Q1FY24 of ₹539.00 Crores down from ₹549.00 Crores year on year, a fall of 1.82%.
Consolidated Net Profit of ₹123.00 Crores up 2.5% from ₹120.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹53.36, up 2.07% from ₹52.28 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.